chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I took my Covid booster shot at around 2:30 on thursday afternoon(Nov 4th). About 10 hours later, I felt extremely dizzy. The dizziness continued the whole of the next day where I was unable to get out of bed. The vertigo (dizziness) was accompanied with vomiting every time I stood up to go to the bathroom. I was unable to keep down any food or water for the entire next day. I am an otherwise healthy person but I needed physical help to get to the bathroom all of friday. On saturday, the nausea went away but the vertigo persisted mildly. It is now Monday and I am still feeling tired and not back to my usual self. In addition to the vertigo and nausea, I did have fever, chills, injection site pain and body aches. The most debilitating symptom was the vertigo and nausea. My husband informed the primary care doctor about the reaction and they wanted me to get admitted in the hospital for IV fluids. But, we decided against it due to my physical inability to get out of bed.
Abnorm fussiness. Cried constantly for 1/2 hr periods. At ER both legs swollen. Slept well. Fussy again next day for 1/2 hr periods. Spit up 5 times large amts. Exam normal on 2/8 but fussy.
Bad acne, very tired, bad headaches, joint pain, auto-immune symptoms - bad circulation in hands and feet. Toe nails stopped growing and fell off. Swollen joints, hands, and feet, memory problems, zoning out, nausea, dizziness, upset stomach.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 18-DEC-2015 at 19:44, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperatures were 8.6 and 6.2 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
On the same day as shot was given, the subject developed raised purple swelling at the injection site area. The injection area was hot to the touch. Treated with Benadryl cream. Symptoms lasted for 3 days. In June 1999 subject developed fatigue and headaches that continue still today. In March 1999, the subject was diagnosed with a H. pylori infection and was treated with antibiotics. She has occasional nausea and abdominal pains still and treats these symptoms with Zantac.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Information on concurrent condition, medical history or concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L043213 and expiry date 28-AUG-2017 (dose and route not reported). No adverse effects were reported. No Product Quality Complaint (PQC) was involved. Details of temperature excursion: Temperature: 48 F Time frame: Undetermined, excursion occurred over the course of several days in February cumulative time frame was not provided Previous excursion: No Data logger involved: Yes. This is one of the two reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a currently 16 years old female patient. The patient was vaccinated with a dose of GARDASIL (dose, route and lot # not reported) on an unspecified date. No other co-suspects were reported. No concomitant medications were reported. The nurse reported that on an unknown date, the patient experienced malaise, fatigue, memory loss and difficulty concentrating after receiving GARDASIL. At the time of the report, the patient had not recovered. Additional information has been requested.
Vaccines given on Thurs, 9/3/09. Mild pain/redness that evening. Major symptoms began Friday afternoon and didn't start getting better until Monday. Urgent Care prescribed on Monday KEFLEX and MEDROL. Symptoms : Extreme pain in arm w/pneumonia shot and widespread arm redness (diagnosed as becoming cellulitis), 101 degrees temperature, body aches, nausea, flu-like signs.
At 3d after vaccine. Severe local reaction: swelling, erythema, warmth, itching. Given Loratidine. 6/4/09- patient states after seeing Dr and taking the Antihistamine he suggested her arm cleaned completely.
Prior to vaccination, I had occasional bouts of minor gas, usually after eating a food that I am sensitive to, like dairy. However, within a day or so after each of the Moderna vaccines, I experienced rectal bleeding and increasing bouts of gas and abdominal pain, eventually being diagnosed with Ulcerative Proctitis in August 2021.    I received my first Moderna vaccine on 4/22/21. On 4/23, I noticed slight red/pink blood when wiping after a bowel movement. On 4/24, I experienced sudden, strong stomach pain/achy bowels and started passing mucus. On 4/25, I again noticed slight red/pink blood when wiping after bowel movement.  For the next few weeks after that, I had occasional (sometimes daily) gas and stomach pain, often after eating foods that are staples in my diet that previously had not caused issues, but no more bleeding.  On 5/20/21, I received my 2nd Moderna vaccine, and became very ill with the typical symptoms of fever, headache, body aches, etc. On 5/23, I was starting to feel better, but again noticed red/pink blood when wiping after a bowel movement. The bleeding continued 5/25, 5/26, 5/28, and onward. The bleeding, gas and occasional abdominal pain continued to get worse over the following weeks. I visited with my PCP and a Gastroenterologist. In July, I began the low FODMAP diet, which helped reduce the symptoms, but did not resolve them completely. In August, a colonoscopy showed inflammation typical of Ulcerative Proctitis. Symptoms have intensified following the colonoscopy. I have been prescribed Mesalazine suppositories.
Kinrix administered to a 2-year-old; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 23-Nov-2022 Reporter's comment: The reporter consented to follow-up. Additional supportive information: The patient received a dose of Kinrix at inappropriate age, which led to inappropriate age at vaccine administration.
Severe pain, muscle tightness in left arm and neck/jaw, low grade fever, vomiting, multiple bruises on left arm, jaw tightness. Went to ER, given steroids, muscle relaxers, and pain medication. Symptoms subsided over the following 1 1/2 weeks.
Patient was administered the COVID 19 vaccine at 15 years old. Pfizer vaccine is only approved for 16 years and above. No adverse reaction occurred after administration.
Skin breakout and extreme itching on face and torso. Two large pustules on face. Bump at injection sight (still there). Itching eased after several days and pustules on face are fading but still red after 20 days.
Received the vaccine in the morning and came to ER later post fall.  he was admitted with a fracture and later transferred to a higher level of care hospital
Presented to ED with abdominal pain (hx of stage IV pancreatic cancer) and admitted for pain control and palliative care. Occurred the day after second dose of Moderna.
blood clots/stroke; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOTIC STROKE (blood clots/stroke) in a 62-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOTIC STROKE (blood clots/stroke) (seriousness criteria hospitalization and medically significant). At the time of the report, THROMBOTIC STROKE (blood clots/stroke) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Company comment: This spontaneous case concerns a 62 year old female patient with no reported medical history who experienced the unexpected, serious (medically significant) adverse event of special interest of Thrombotic Stroke that occurred on an unknown date after receiving a second dose of mRNA1273 as COVID-19 vaccine. No further details about the clinical course, diagnostic procedures and treatments were provided in the case.  The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-566820, MOD-2022-566822, MOD-2022-566821, MOD-2022-566718, MOD-2022-566814, MOD-2022-566808, MOD-2022-566839 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2022: Follow up received included: Non-significant information.; Sender's Comments: This spontaneous case concerns a 62 year old female patient with no reported medical history who experienced the unexpected, serious (medically significant) adverse event of special interest of Thrombotic Stroke that occurred on an unknown date after receiving a second dose of mRNA1273 as COVID-19 vaccine. No further details about the clinical course, diagnostic procedures and treatments were provided in the case.  The benefit-risk relationship of mRNA-1273 is not affected by this report.
I thought I had Covid-19 and needed to see a doctor because of a dry cough. My chest was tight and it was hard to breath. I had a fever of 100.3. I was prescribed an Albuterol inhaler and Tessalon(suppressant). I had been taking Nyquil every night and round the clock Tylenol and Ibuprofen. I had full body fatigue and terrible body aches. My muscles hurt. A few days later my fever was down and I was having chest tightness. I tested negative for on the rapid test on the 10th PCR test negative repeated that same week and negative. I felt bad for nine days after vaccination. I was still exhausted for another week at work. I got the second dose and had no problems.
Redness noted over the area of the deltoid where DTaP vaccine was administered; edema and warmth present.  Denies signs of pain.  Patient tolerating active and passive ROM of the shoulder left and arm.  Appears to be a local skin reaction to the vaccine. Area of redness is approximately 5cmx4cm.
Swelling, erythema at injection site measured 10 cm x 12 cm; tender with mild warmth.
Rash, itching/Painful. 7/14-07. Pt confused night of 7-13-07
sick in stomach; sick in stomach; arm hurts; slept for 12 hours; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9262; Expiration Date: 21May2100), dose 2 via an unspecified route of administration, administered in Deltoid Left on 12Feb2021 14:30 (at the age of 74years) as dose 2, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 on 22Jan2021 in which the patient experienced for a couple minutes she can't think, arm hurts, pain in head/ head it just felt like a bowling ball, it's still heavy, and slept for 12hours (she doesn't usually sleep that much). The patient experienced sick in stomach on 12Feb2021, arm hurts, and had to sleep (slept for 12 hours, she doesn't usually sleep that much on 12Feb2021. The outcome of events was recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected.
Vaccine administered 6-20-12. Pt returned to clinic 6/22/12 complained of nausea, vomiting. Swelling and redness at injection site. Fever 101.2. Cellulitis (L) arm. Patient given Clindamycin 300mg one p.o TID x 7 days.
Patient received the Janssen Vaccination despite being 16. DOB was entered originally as 18 but found they were 16 on second shot. Not currently suggested for pt to get Janssen when under 18. As per patient's parents there were no current side effects.
Information has been received from a nurse practitioner concerning a 65 year old male with medical history and drug reactions/allergies reported as unspecified who on 28-NOV-2006 was vaccinated with Pneumovax 23.  Concomitant therapy unspecified.  On 29-NOV-2006, the patient experienced redness at the site of injection.  The patient sought medical attention.  The patient was treated with antibiotics.  No lab diagnostic tests were performed.  At the time of reporting, the patient was recovering.  No further information is available.
I had right sided headache for the first two days, then resolved.  The right sided headaches recurred along with right tongue numbness initially on 12/29/2020.  The symptoms worsen on 12/31/2020 and severe on 1/1/2021.  I was initially started on Valtrex thinking it maybe due to shingles but soon with the right sided facial paralysis, it was obvious it was Bell's Palsy and was started on steriods on 1/1/21 and also received acupuncture treatment on 1/2/21 which significant help improve the symptoms.  I still have some residual weakness of the right eye with some tearing and mouth weakness.
Within 30-40 minutes  after getting the booster in my right arm,  My right ring finger got itchy, hurt a little and became swollen and turned purple. The purple was on the entire back side of my finger from the base up to the almost the tip.  After a few days the purple looked like it was coming around to the sides of fingers.  The swelling went down the next day but remained purple.  It has been 2 weeks and my finger is still purple. It looks lighter at times and darker and gets flared when putting alot of pressure on it such as writing.
The day after patient received his vaccines I noticed bumps on his body, mainly his thighs and arms. The next day, two days after the vaccines the bumps started to spread pretty bad. By three days after the vaccines his body was covered in red bumps all over his body. His face, armpits, back, stomach, legs, feet and his butt.
The patient called 4/12/18 at 12:16 PM to report that she thought she might be having a reaction to the PREVNAR 13. Patient was ask when she started having symptoms and stated that the next day 4/7/18 her right arm was sore and by day 3 after injection 4/9/18 redness appeared around the site area. Patient then said that today 4/12/18 that the red area is 2" x 2", swollen, is warm to touch, and itches. Patient denies any shortness of breath. Patient was advise to use a cold compress, to take BENADRYL and if symptoms worsened or she became short of breath to go to the ER. Reaction was document in patient's chart and added to her allergy list and VAERS report filed.
10 1/2 cm x 7 1/2 cm area of erythema to left upper lateral thigh - slightly warm to the touch.  Motrin q 6-8 hrs PRN.
Began with nausea on the evening of 01/24/11. Felt worse on the day and evening of 01/25/11 and developed a low grade fever. At 4:00 AM-6:00 AM 01/26/11 patient had a fever of 103'F p.o. She took 3 Ibuprofen and called the nurse at 10:33 AM. She was scheduled in Urgent Care. Her fever was down to 99.2'F p.o. and her Rt arm was visibly swollen with warmth, tenderness and localized red patches on upper Rt arm and very painful to move Rt arm.
Skin around both my eyes are red and looks like an allergic reaction and it feels like a burning sensation. This happened only an hour after my second shot.
Pt reported not feeling well the evening after the vaccine, within 7 days his legs were weak, 14 days out his muscles were sore and crampy. After 20 days his hands and feet were numb and legs were very weak. The PT proceeded to the ED and was referred to a larger hospital for evaluation. The PT was hospitalized for 3 days, discharged and is now following up with physical therapy and a neurologist.
Swelling in the area at the base of the neck on the left shoulder; swelling in the area at the base of the neck on the left shoulder, (there was a small lump in that area); Soreness/tenderness in the area near the collarbone; Soreness/tenderness in the area near the collarbone; Pain in the left armpit; Swollen lymph node; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ELI283 and expiry date: unknown), via an unspecified route of administration on the left arm, on 18Jan2021 12:15 at single dose for covid-19 immunisation. Medical history included high blood pressure and seasonal allergies. Patient was not pregnant at the time of vaccination. Concomitant medication included losartan potassium, naproxen sodium (ALEVE) and unspecified OTC allergy medications. There were no other vaccines received within 4 weeks prior to COVID vaccination. The patient experienced pain in the left armpit and swollen lymph node on 23Jan2021 11:30. On 24Jan2021 17:00, patient experienced swelling in the area at the base of the neck on the left shoulder, (there was a small lump in that area) and soreness/tenderness in the area near the collarbone. Patient had not recovered from the events and had not received any treatment. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
pt devel a papular rash on trunk & arms; a macular rash on cheeks; small pustle lesions on the forehead & nose; blotches on face; afebrile; sx began on day 4 p/DTaP/HIB vax; no exudate present in eyes; no rhinorrhea;
PT. CALLED TO C/O SHOULDER PAIN & FEELS A NERVE WAS HIT DURING GARDASIL INJECTION
Pt reported to the pharmacy on 10/24 stating that his arm was swollen and still hurting from his pneumonia and flu injections on Thursday 10/22. Pt stated that the pain had improved but it was still swollen and red. Upon examination pts arm looked red from elbow to bicep area, and it was clearly swollen. Pt stated that he had only taken Tylenol to help with the symptoms when he reported on 10/24. I recommended that the pt continue to take Tylenol or Ibuprofen to help with the pain and redness/swelling, as well as to use an ice pack. I also alerted the patient that if it did not improve he could visit an urgent care facility for further evaluation. Pt was agreeable to these ideas and stated that "he figured it would go away eventually". I told the patient I would follow up with him to see improvement of arm.
I had the shot at 11:30 am, and by 5:00 pm I was having extreme chills and uncontrollable shaking.  My body ached and I had a headache.  My eyes turned very red.  I took 2 Aleve and went to bed.  Within a couple hours, the shaking had stopped but still had aching body and headache.  Next morning I had hot flashes and sweating.  I took my blood pressure and it was 101/61.  I normally have high blood pressure even taking my medications.
Chest pain and tightness for over 24 hours after receiving the vaccine, still continuing as of this report.
Information has been received from a physician and a practice manager referring to a patient of  unknown age and gender. On 14-JUL-2016 the patient was vaccinated with an improperly stored dose of VAQTA 50 U/1 ml (lot # L027735, expiration date 12-JAN-2017, dose and route not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 48 hours, the lowest recorded temperature was 34 Fahrenheit degree and the type of excursion was refrigerator (R). The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
Itchy injection site; red injection site; Swollen injection site; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE SWELLING (Swollen injection site) and INJECTION SITE ERYTHEMA (red injection site) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE SWELLING (Swollen injection site). On 30-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Itchy injection site) and INJECTION SITE ERYTHEMA (red injection site). At the time of the report, INJECTION SITE PRURITUS (Itchy injection site) and INJECTION SITE ERYTHEMA (red injection site) outcome was unknown and INJECTION SITE SWELLING (Swollen injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
relatively mild fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (relatively mild fatigue) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (relatively mild fatigue). At the time of the report, FATIGUE (relatively mild fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to (Patient Link).
Patient had prolonged fever (8 days) after receiving first Hepatits A (Vaqta) vaccine. Seen twice by providers and thought to be viral.  Received booster dose of Hepatitis A (Vaqta) 6 months later and again had prolonged fever after vaccination ( approx 5 days). Was also diagnosed with droup, sinusitis and left otitis media 5 days after vaccination, during prolonged fever.
he had an antibody titer drawn that was negative- no antibodies; This is a spontaneous report from a contactable physician (reporting for himself).  A male patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, bacth/lot no. and expiry date unknown), via an unspecified route of administration on 05Jan2021 (2nd dose) at single dose for COVID-19 immunization. Patient medical history included chronic myelocytic leukemia and was taking dasatinib (SPRYCEL)  and Jak (?). He was taking 30 mg of Jak and 100 mg of dasatinib. Patient first received his first dose of PFIZER vaccine on 16Dec2020. On 05Jan2021, patient received 2nd dose of vaccine. He had an antibody titer drawn that was negative- no antibodies on 05Jan2021. He understands per literature that patients on immunosuppressant therapy can have a diminished response to vaccine. He understands that in the clinical trials, some patients received a higher dose of the vaccine. He wanted to talk to someone about this. Wondering if he should check his antibodies titre in another week or should he get another dose of the vaccine or higher dose of it. Outcome of the event COVID-19 antibody test negative was unknown.   Information on the Lot/Batch number has been requested.